Report Detail

Pharma & Healthcare Streptococcus pyogenes Infections - Pipeline Review, H1 2019

  • RnM2890024
  • |
  • 06 February, 2019
  • |
  • Global
  • |
  • 35 Pages
  • |
  • Global Markets Direct
  • |
  • Pharma & Healthcare

Streptococcus pyogenes Infections - Pipeline Review, H1 2019

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Streptococcus pyogenes Infections - Pipeline Review, H1 2019, provides an overview of the Streptococcus pyogenes Infections (Infectious Disease) pipeline landscape.

Streptococcus pyogenes infections are caused by Streptococcus pyogenes, a spherical, Gram-positive bacterium. Symptoms include significant pain, swelling, and redness of infected area, fever, dizziness, difficulty breathing, dangerously low blood pressure, and a weak, rapid pulse. Treatment includes antibiotics and healthy lifestyle.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Streptococcus pyogenes Infections - Pipeline Review, H1 2019, provides comprehensive information on the therapeutics under development for Streptococcus pyogenes Infections (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Streptococcus pyogenes Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Streptococcus pyogenes Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in IND/CTA Filed, Preclinical and Discovery stages are 1, 4 and 2 respectively. Similarly, the Universities portfolio in Phase I and Preclinical stages comprises 1 and 1 molecules, respectively.

Streptococcus pyogenes Infections (Infectious Disease) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Streptococcus pyogenes Infections (Infectious Disease).
- The pipeline guide reviews pipeline therapeutics for Streptococcus pyogenes Infections (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Streptococcus pyogenes Infections (Infectious Disease) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Streptococcus pyogenes Infections (Infectious Disease) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Streptococcus pyogenes Infections (Infectious Disease)

Reasons to buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Streptococcus pyogenes Infections (Infectious Disease).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Streptococcus pyogenes Infections (Infectious Disease) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.


Table of Contents

    List of Tables

      List of Figures

        Introduction

          Global Markets Direct Report Coverage

            Streptococcus pyogenes Infections - Overview

              Streptococcus pyogenes Infections - Therapeutics Development

                Pipeline Overview

                  Pipeline by Companies

                    Pipeline by Universities/Institutes

                      Products under Development by Companies

                        Products under Development by Universities/Institutes

                          Streptococcus pyogenes Infections - Therapeutics Assessment

                            Assessment by Target

                              Assessment by Mechanism of Action

                                Assessment by Route of Administration

                                  Assessment by Molecule Type

                                    Streptococcus pyogenes Infections - Companies Involved in Therapeutics Development

                                      Absynth Biologics Ltd

                                        AstraZeneca Plc

                                          Cadila Pharmaceuticals Ltd

                                            Crestone Inc

                                              Helix BioMedix Inc

                                                Wellstat Vaccines LLC

                                                  Streptococcus pyogenes Infections - Drug Profiles

                                                    (mupirocin calcium + neomycin sulfate + HT-61) - Drug Profile

                                                      Product Description

                                                        Mechanism Of Action

                                                          R&D Progress

                                                            AZ-6142 - Drug Profile

                                                              Product Description

                                                                Mechanism Of Action

                                                                  R&D Progress

                                                                    HB-1345 - Drug Profile

                                                                      Product Description

                                                                        Mechanism Of Action

                                                                          R&D Progress

                                                                            Small Molecules to Inhibit PolC for Gram-Positive Bacterial Infections - Drug Profile

                                                                              Product Description

                                                                                Mechanism Of Action

                                                                                  R&D Progress

                                                                                    Streptococcus [serotype A] vaccine - Drug Profile

                                                                                      Product Description

                                                                                        Mechanism Of Action

                                                                                          R&D Progress

                                                                                            streptococcus pyogenes (30-valent) vaccine - Drug Profile

                                                                                              Product Description

                                                                                                Mechanism Of Action

                                                                                                  R&D Progress

                                                                                                    Streptococcus pyogenes vaccine - Drug Profile

                                                                                                      Product Description

                                                                                                        Mechanism Of Action

                                                                                                          R&D Progress

                                                                                                            Streptococcus pyogenes vaccine - Drug Profile

                                                                                                              Product Description

                                                                                                                Mechanism Of Action

                                                                                                                  R&D Progress

                                                                                                                    Streptococcus pyogenes vaccine - Drug Profile

                                                                                                                      Product Description

                                                                                                                        Mechanism Of Action

                                                                                                                          R&D Progress

                                                                                                                            Streptococcus pyogenes Infections - Dormant Projects

                                                                                                                              Streptococcus pyogenes Infections - Discontinued Products

                                                                                                                                Appendix

                                                                                                                                  Methodology

                                                                                                                                    Coverage

                                                                                                                                      Secondary Research

                                                                                                                                        Primary Research

                                                                                                                                          Expert Panel Validation

                                                                                                                                            Contact Us

                                                                                                                                              Disclaimer

                                                                                                                                              Summary:
                                                                                                                                              Get latest Market Research Reports on Streptococcus pyogenes Infections. Industry analysis & Market Report on Streptococcus pyogenes Infections is a syndicated market report, published as Streptococcus pyogenes Infections - Pipeline Review, H1 2019. It is complete Research Study and Industry Analysis of Streptococcus pyogenes Infections market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

                                                                                                                                              Last updated on

                                                                                                                                              REPORT YOU MIGHT BE INTERESTED

                                                                                                                                              Purchase this Report

                                                                                                                                              $2,000.00
                                                                                                                                              $4,000.00
                                                                                                                                              $6,000.00
                                                                                                                                              1,584.00
                                                                                                                                              3,168.00
                                                                                                                                              4,752.00
                                                                                                                                              1,852.00
                                                                                                                                              3,704.00
                                                                                                                                              5,556.00
                                                                                                                                              302,700.00
                                                                                                                                              605,400.00
                                                                                                                                              908,100.00
                                                                                                                                              166,800.00
                                                                                                                                              333,600.00
                                                                                                                                              500,400.00
                                                                                                                                              Credit card Logo

                                                                                                                                              Related Reports


                                                                                                                                              Reason to Buy

                                                                                                                                              Request for Sample of this report